Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug
by The CNS Summit Rater Training and Certification Committee: Mark D. West; David G. Daniel, MD; Mark Opler, PhD, MPH; Alexandria Wise-Rankovic, PhD; and Amir Kalali, MD Mr. West is
by Richard G. Cockerill; Bridget K. Biggs, PhD; Tyler S. Oesterle, MD; and Paul E. Croarkin, DO Mr. Cockerill is a student at Mayo Medical School, College of Medicine, Mayo
by Julie P. Gentile, MD; Paulette Marie Gillig, MD, PhD; Kelly Stinson, MD; and Jeremy Jensen, MD Dr. Gentile is Professor, Department of Psychiatry, Wright State University, Dayton, Ohio; Dr.
by Jae Lee, DO; Laura Arcand; Puneet Narang, MD; and Steven Lippmann, MD Dr. Lee is Resident Physician, Hennepin-Regions Psychiatry Program, Minneapolis-St. Paul, Minneapolis; Ms. Arcand is physician assistant student,
by Steven D. Targum and Lenard A. Adler Steven D. Targum, MD, is the scientific director at Clintara LLC, the chief medical officer at Methylation Sciences Inc., BrainCells Inc., and